"We feel very positive about this market," says Hsu Te-man, deputy general manager of Hsin-tung Pharmaceuticals, which is already concentrating on transdermal patches as its principle future market. After conducting market research the company decided to enter the field early, and to back ITRI's plan with investment and support.
「我們非常看好這個市場」，已經將貼劑鎖定為將來市場主力的信東藥廠副總經理許德滿指出，經過市場調查，他們決定攻佔這個未來的市場，投入資金、全力支持工研院的計畫。